Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2623-2026

GC Agar Base (150mm) 10/PK R04030; GC Agar Base (100mm) 10/PK R01460 Recall

GC Agar Base (150mm) 10/PK R04030; GC Agar Base (100mm) 10/PK R01460

FDA recall Class II

Ongoing

FDA lists this Class II recall for GC Agar Base (150mm) 10/PK R04030; GC Agar Base (100mm) 10/PK R01460. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2623-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Jun 3, 2026
FDA report date
Jul 8, 2026
Quantity in commerce
1573
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

GC Agar Base (150mm) 10/PK R04030; GC Agar Base (100mm) 10/PK R01460

Affected model & UDI checker

Search the exact identifiers published for Z-2623-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedGC Agar Base (150mm) 10/PK R04030; GC Agar Base (100mm) 10/PK R01460Check source notice848838001796
Not specifiedGC Agar Base (150mm) 10/PK R04030; GC Agar Base (100mm) 10/PK R01460Check source notice848838004469
FDA code information

R01460 - GC Agar Base (100mm) 10/PK UDI-DI 848838001796 Lots 338950 356898 359912 365679 371863 376799 382136 384712 393488 396333 402458; R04030 - GC Agar Base (150mm) 10/PK UDI-DI 848838004469 Lots 336864 345992 348754 359925 367829 374235 376786 381488 385224 391312 393478

View the original FDA recall notice

Why was this product recalled?

Reduced or no recovery of some strains of Neisseria gonorrhoeae.

What actions did Remel, Inc take?

On June 3, 2026, the firm began notifying customers via letters titled Urgent Medical Device Recall. Customers were instructed to destroy any remaining inventory of affected lots and inform the recalling firm of the amount destroyed to receive a replacement or credit. In addition, customers should notify necessary personnel. Users should review previously reported results generated using the affected lots and assess whether retesting is appropriate based on laboratory procedures.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology